IL148581A0 - Sodium-hydrogen exchanger type 1 inhibitor crystals - Google Patents

Sodium-hydrogen exchanger type 1 inhibitor crystals

Info

Publication number
IL148581A0
IL148581A0 IL14858100A IL14858100A IL148581A0 IL 148581 A0 IL148581 A0 IL 148581A0 IL 14858100 A IL14858100 A IL 14858100A IL 14858100 A IL14858100 A IL 14858100A IL 148581 A0 IL148581 A0 IL 148581A0
Authority
IL
Israel
Prior art keywords
sodium
exchanger type
hydrogen exchanger
inhibitor crystals
crystals
Prior art date
Application number
IL14858100A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL148581A0 publication Critical patent/IL148581A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
IL14858100A 1999-10-29 2000-10-09 Sodium-hydrogen exchanger type 1 inhibitor crystals IL148581A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16237499P 1999-10-29 1999-10-29
PCT/IB2000/001460 WO2001030759A2 (fr) 1999-10-29 2000-10-09 Cristaux d'inhibiteurs de l'echangeur sodium-hydrogene de type 1

Publications (1)

Publication Number Publication Date
IL148581A0 true IL148581A0 (en) 2002-09-12

Family

ID=22585355

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14858100A IL148581A0 (en) 1999-10-29 2000-10-09 Sodium-hydrogen exchanger type 1 inhibitor crystals

Country Status (44)

Country Link
EP (1) EP1224179B1 (fr)
JP (1) JP2003512455A (fr)
KR (1) KR100464526B1 (fr)
CN (2) CN1205205C (fr)
AP (1) AP2002002493A0 (fr)
AR (1) AR029402A1 (fr)
AT (1) ATE271047T1 (fr)
AU (1) AU778573B2 (fr)
BG (1) BG106729A (fr)
BR (1) BR0015275A (fr)
CA (1) CA2389020A1 (fr)
CO (1) CO5271714A1 (fr)
CZ (1) CZ20021332A3 (fr)
DE (1) DE60012208T2 (fr)
DK (1) DK1224179T3 (fr)
DZ (1) DZ3463A1 (fr)
EA (1) EA004937B1 (fr)
EE (1) EE200200227A (fr)
ES (1) ES2222923T3 (fr)
GE (1) GEP20043222B (fr)
GT (1) GT200000180A (fr)
HK (1) HK1048472B (fr)
HR (1) HRP20020366B1 (fr)
HU (1) HUP0204009A3 (fr)
IL (1) IL148581A0 (fr)
IS (1) IS6302A (fr)
MA (1) MA26840A1 (fr)
MX (1) MXPA02004358A (fr)
NO (1) NO20021821D0 (fr)
NZ (1) NZ517738A (fr)
OA (1) OA12080A (fr)
PA (1) PA8505501A1 (fr)
PE (1) PE20010764A1 (fr)
PL (1) PL354869A1 (fr)
PT (1) PT1224179E (fr)
SI (1) SI1224179T1 (fr)
SK (1) SK5312002A3 (fr)
SV (1) SV2002000209A (fr)
TN (1) TNSN00210A1 (fr)
TR (1) TR200201167T2 (fr)
UA (1) UA72002C2 (fr)
WO (1) WO2001030759A2 (fr)
YU (1) YU31502A (fr)
ZA (1) ZA200203295B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441176B1 (en) 1999-10-29 2002-08-27 Pfizer Inc. Method for preparing sodium-hydrogen exchanger type 1 inhibitor
EP1355899A1 (fr) * 2001-01-31 2003-10-29 Pfizer Products Inc. Ethanolats d'inhibiteur de type 1 d'echangeur sodium-hydrogene
CA2472342A1 (fr) * 2002-01-30 2003-08-07 Pfizer Products Inc. Compositions pharmaceutiques de zoniporide mesylate et procedes d'amelioration de la solubilite du zoniporide
WO2003092694A1 (fr) * 2002-05-02 2003-11-13 Pfizer Products Inc. Traitement du diabete et de complications diabetiques a l'aide d'inhibiteurs nhe-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46200A (sh) * 1998-02-27 2003-02-28 Pfizer Products Inc. N-(supstituisani peto-članog di-ili triaza dinezasićenog prstena)karbonil/guanidin derivati za tretiranje ishemije

Also Published As

Publication number Publication date
EP1224179B1 (fr) 2004-07-14
TR200201167T2 (tr) 2002-08-21
HK1048472A1 (en) 2003-04-04
MXPA02004358A (es) 2002-11-07
EP1224179A2 (fr) 2002-07-24
NZ517738A (en) 2005-06-24
WO2001030759A3 (fr) 2001-09-13
HRP20020366B1 (en) 2005-04-30
SI1224179T1 (en) 2004-10-31
NO20021821L (no) 2002-04-18
MA26840A1 (fr) 2004-12-20
ZA200203295B (en) 2003-06-25
GT200000180A (es) 2002-04-11
WO2001030759A2 (fr) 2001-05-03
KR100464526B1 (ko) 2005-01-03
CZ20021332A3 (cs) 2002-10-16
HUP0204009A2 (hu) 2003-03-28
ES2222923T3 (es) 2005-02-16
DE60012208D1 (de) 2004-08-19
BR0015275A (pt) 2002-07-16
UA72002C2 (en) 2005-01-17
CA2389020A1 (fr) 2001-05-03
NO20021821D0 (no) 2002-04-18
CN1636991A (zh) 2005-07-13
YU31502A (sh) 2004-12-31
EA004937B1 (ru) 2004-10-28
KR20020040918A (ko) 2002-05-30
PA8505501A1 (es) 2003-09-05
AU778573B2 (en) 2004-12-09
GEP20043222B (en) 2004-04-26
DZ3463A1 (fr) 2001-05-03
DK1224179T3 (da) 2004-10-25
PE20010764A1 (es) 2001-07-23
DE60012208T2 (de) 2005-07-21
SV2002000209A (es) 2002-07-16
PT1224179E (pt) 2004-10-29
PL354869A1 (en) 2004-03-08
SK5312002A3 (en) 2003-01-09
TNSN00210A1 (fr) 2005-11-10
ATE271047T1 (de) 2004-07-15
HUP0204009A3 (en) 2004-07-28
OA12080A (en) 2003-08-25
AP2002002493A0 (en) 2002-06-30
JP2003512455A (ja) 2003-04-02
IS6302A (is) 2002-03-15
HK1048472B (zh) 2005-09-16
EA200200416A1 (ru) 2002-10-31
AR029402A1 (es) 2003-06-25
CN1384829A (zh) 2002-12-11
BG106729A (bg) 2002-12-29
AU7441500A (en) 2001-05-08
CO5271714A1 (es) 2003-04-30
CN1205205C (zh) 2005-06-08
HRP20020366A2 (en) 2004-02-29
EE200200227A (et) 2003-06-16

Similar Documents

Publication Publication Date Title
EP1164345A4 (fr) Echangeur de chaleur
IL146288A0 (en) Vla-4 inhibitor compounds
IL149097A0 (en) 4-carboxyamino-2-ethyl-1,2,3,4-thetrahydroquinoline crystal as cetp inhibitor
IL130438A (en) Heat exchanger
EP1227974A4 (fr) Echangeur thermique ameliore
GB9818185D0 (en) Heat exchanger
PL342763A1 (en) Matrix metaloprotease inhibitor
GB2333972B (en) Brazed plates cryogenic condenser
EP1136783A4 (fr) Echangeur de chaleur
GB2343643B (en) Heat exchanger
PL354869A1 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals
DZ3310A1 (fr) Inhibiteurs de l'echangeur sodium-hydrogene de type 1
GB2389113B (en) B-secretase inhibitor
GB9928207D0 (en) Heat exchanger
HUP9903032A3 (en) Heat exchanger unit
IL139198A0 (en) Method for preparing sodium-hydrogen exchanger type 1 inhibitor
GB9824648D0 (en) Heat exchanger
EP1256771A4 (fr) Echangeur de chaleur
GB9926629D0 (en) Heat exchangers
GB9911761D0 (en) Heat exchanger
AU140637S (en) Cooler
GB9901538D0 (en) Heat exchanger
GB9803871D0 (en) Heat exchanger
EP1111322A4 (fr) Echangeur thermique
GB9827817D0 (en) Type 11 Dehydroquinase inhibitors